Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling (Q43240270)

17 November 2017

title

Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling (English)

1 reference

17 November 2017

Ans Punt

1

1 reference

17 November 2017

Suzanne M Jeurissen

2

1 reference

17 November 2017

Marelle G Boersma

3

1 reference

17 November 2017

Thierry Delatour

4

1 reference

17 November 2017

Gabriele Scholz

5

1 reference

17 November 2017

Benoît Schilter

6

1 reference

17 November 2017

Peter J van Bladeren

7

1 reference

17 November 2017

Ivonne M C M Rietjens

8

1 reference

17 November 2017

publication date

17 November 2009

1 reference

17 November 2017

published in

Toxicological Sciences

1 reference

17 November 2017

volume

113

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

337-348

1 reference

Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1'-hydroxyestragole

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Hepatocarcinogenicity of Estragole (1-Allyl-4-methoxybenzene) and 1′-Hydroxyestragole in the Mouse and Mutagenicity of 1′-Acetoxyestragole in Bacteria 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Sulfotransferases in the bioactivation of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

In vitro measurements of metabolism for application in pharmacokinetic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Inhibitors of type II 17beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

The metabolic disposition of [methoxy-14C]-labelled trans-anethole, estragole and p-propylanisole in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Metabolism of styrene in the human liver in vitro: interindividual variation and enantioselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFP272

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFP272

1 reference

17 November 2017

1 reference